Benitec Biopharma
BNTC
BNTC
21 hedge funds and large institutions have $2.54M invested in Benitec Biopharma in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $4.16M → $2.54M (-$1.62M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$137K | |
| 2 | +$87K | |
| 3 | +$4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.7K |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.03K |
Top Sellers
| 1 | -$27K | |
| 2 | -$8.15K | |
| 3 | -$2.24K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$11 |